This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

FAQ

It is currently Wed Jun 19, 2013 9:04 am

View unanswered posts | View active topics

Board index » Multiple Sclerosis » Drug Pipeline

All times are UTC - 8 hours [ DST ]

NNZ-2566

Page 1 of 1

[ 1 post ]

Print view

Previous topic | Next topic

Author

Message

bromley

Post subject: NNZ-2566

Posted: Sat Mar 25, 2006 8:22 am

Family Elder

Joined: Fri Sep 10, 2004 3:00 pm
Posts: 1889

This is one of the drugs in the pipeline at Neuren. It is a neuro-protective drug and pre-clinical results look promising. I think it has just entered into Phase 1 human trials.

See 22 March news on the company's website.

Let's hope that the human trial results are as good

<shortened url>

Top

Page 1 of 1

[ 1 post ]

Board index » Multiple Sclerosis » Drug Pipeline

All times are UTC - 8 hours [ DST ]

Related topics
Topics	Author	Replies	Views	Last post
	NNZ-2566	bromley	0	1128	Mon Mar 06, 2006 11:44 am bromley

Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Jump to:

Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!

Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers

This site does not offer, or claim to offer, medical, legal, or professional advice. All treatment decisions should always be made with the full knowledge of your physicians.